97 related articles for article (PubMed ID: 9755330)
21. [Research on relationship of survivin gene expression with malignant proliferation and apoptosis of brain glioma].
Zhen HN; Zhang X; Hu PZ; Fu LA; Yang TT; Ma FC; Wang XL; Liang JW
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):885-8. PubMed ID: 16083611
[TBL] [Abstract][Full Text] [Related]
22. Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling.
Shibuya M; Hoshino T; Ito S; Wacker MR; Prados MD; Davis RL; Wilson CB
Neurosurgery; 1992 Apr; 30(4):494-7; discussion 497-8. PubMed ID: 1584346
[TBL] [Abstract][Full Text] [Related]
23. Comparison of 5-bromo-2-deoxyuridine and [3H]thymidine for studies of hepatocellular proliferation in rodents.
Lanier TL; Berger EK; Eacho PI
Carcinogenesis; 1989 Jul; 10(7):1341-3. PubMed ID: 2736724
[TBL] [Abstract][Full Text] [Related]
24. Apoptotic cell death induced by local brain hyperthermia in a rat glioma model.
Uesugi S; Yamashita K; Nakashima K; Ito H
Acta Neuropathol; 1998 Oct; 96(4):351-6. PubMed ID: 9796999
[TBL] [Abstract][Full Text] [Related]
25. Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients.
Lamborn KR; Prados MD; Kaplan SB; Davis RL
Cancer; 1999 Feb; 85(4):925-35. PubMed ID: 10091772
[TBL] [Abstract][Full Text] [Related]
26. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat.
Chen J; Li Y; Katakowski M; Chen X; Wang L; Lu D; Lu M; Gautam SC; Chopp M
J Neurosci Res; 2003 Sep; 73(6):778-86. PubMed ID: 12949903
[TBL] [Abstract][Full Text] [Related]
27. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
[TBL] [Abstract][Full Text] [Related]
28. Cell-kinetic characteristics of human brain tumors.
Assietti R; Butti G; Magrassi L; Danova M; Riccardi A; Gaetani P
Oncology; 1990; 47(4):344-51. PubMed ID: 2367061
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies.
Girino M; Riccardi A; Luoni R; Ucci G; Cuomo A
Acta Haematol; 1991; 85(1):26-30. PubMed ID: 2011926
[TBL] [Abstract][Full Text] [Related]
30. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
Benazzo M; Mevio E; Occhini A; Franchini G; Danova M
ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):39-43. PubMed ID: 7700609
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor-driven glioma growth and vascularization in an orthotopic rat model monitored by magnetic resonance imaging.
Goldbrunner RH; Bendszus M; Sasaki M; Kraemer T; Plate KH; Roosen K; Tonn JC
Neurosurgery; 2000 Oct; 47(4):921-9; discussion 929-30. PubMed ID: 11014432
[TBL] [Abstract][Full Text] [Related]
32. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging.
Kim B; Chenevert TL; Ross BD
Clin Cancer Res; 1995 Jun; 1(6):643-50. PubMed ID: 9816027
[TBL] [Abstract][Full Text] [Related]
33. The sequential changes in DNA synthesis, glucose utilization, protein synthesis, and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy.
Takeda N; Diksic M; Yamamoto YL
Cancer; 1996 Mar; 77(6):1167-79. PubMed ID: 8635140
[TBL] [Abstract][Full Text] [Related]
34. Prognostic implications of the proliferative potential of low-grade astrocytomas.
Hoshino T; Rodriguez LA; Cho KG; Lee KS; Wilson CB; Edwards MS; Levin VA; Davis RL
J Neurosurg; 1988 Dec; 69(6):839-42. PubMed ID: 3193189
[TBL] [Abstract][Full Text] [Related]
35. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
[TBL] [Abstract][Full Text] [Related]
36. [Expression of apoptosis and proliferation related genes in carcinogenesis of lung squamous cell carcinoma in rats].
Wang J; Chen HL; Zhu RQ; Diao LM; Jang M; Yang F; Liu MQ
Ai Zheng; 2003 May; 22(5):471-6. PubMed ID: 12753705
[TBL] [Abstract][Full Text] [Related]
37. Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.
Teodori L; Trinca ML; Goehde W; Hemmer J; Salvati F; Storniello G; Mauro F
Int J Cancer; 1990 Jun; 45(6):995-1001. PubMed ID: 2161804
[TBL] [Abstract][Full Text] [Related]
38. Proliferative potential of brain metastases.
Cho KG; Hoshino T; Pitts LH; Nomura K; Shimosato Y
Cancer; 1988 Aug; 62(3):512-5. PubMed ID: 3390791
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.
McKeever PE; Ross DA; Strawderman MS; Brunberg JA; Greenberg HS; Junck L
J Neuropathol Exp Neurol; 1997 Jul; 56(7):798-805. PubMed ID: 9210876
[TBL] [Abstract][Full Text] [Related]
40. Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival or recurrence in brain-tumor patients.
Nishizaki T; Orita T; Kajiwara K; Ikeda N; Ohshita N; Nakayama H; Furutani Y; Ikeyama Y; Akimura T; Kamiryo T
J Neurosurg; 1990 Sep; 73(3):396-400. PubMed ID: 1696625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]